Language Switcher for Asiarecords

DVN, A Wellous Brand, Recognised by ASIA Records for Most Collagen Chewable Tablets Featuring Triple Peptide Sold in a Single Year

ASIA Records is proud to officially recognise DVN, a Wellous brand, for achieving a significant continental milestone as the:

Most Collagen Chewable Tablets Featuring Triple Peptide Sold in a Single Year
(431,601 Units | USD 25.3 Million / IDR 417.5 Billion | July 2024 – July 2025)

With 431,601 units sold within a single year, representing USD 25.3 million / IDR 417.5 billion in sales, the achievement reflects the strong consumer response to DVN and Wellous Indonesia’s approach to making functional health and beauty products more accessible and convenient.

Combining Collagen Innovation with Strong Market Demand

DVN is developed as a chewable collagen supplement designed to make daily beauty and wellness routines more convenient.

Its formulation features Collagen-Tripep20 from South Korea, VIQUA Pomegranate Extract, and HYTOLIVE Olive Polyphenol, together with ingredients including Hydrolyzed Fish Collagen, Vitamin C, L-Glutathione, Sodium Hyaluronate, and Japanese Knotweed Extract.

Between July 2024 and July 2025, DVN recorded 431,601 units sold, with a total sales value of USD 25.3 million / IDR 417.5 billion, reflecting strong consumer adoption and growing demand for accessible beauty-from-within solutions.

Advancing Accessible Health and Beauty Across the Region

Wellous was founded on the belief that good health should be easier to access and integrate into everyday life.

Through DVN, this philosophy extends into the functional beauty category by combining science-backed ingredients with a convenient chewable format. The achievement reflects Wellous Indonesia’s continued growth in Southeast Asia and its commitment to developing practical health and wellness solutions that respond to evolving consumer needs.

A Milestone Moment of Acknowledgement

The ASIA Records recognition was officially presented on 27 August 2026 at Chillax Sudirman, Jakarta, Indonesia, commemorating DVN’s continental record achievement.

The recognition was received by Racheal Tan, Executive Director of Wellous, and Ary Sidabutar, Wellous Indonesia Country Manager, together with members of the Wellous team.

Voices of Leadership

Reflecting on the achievement, Ary Sidabutar, Wellous Indonesia Country Manager, shared:

“From July 2024 to July 2025, DVN reached an important milestone with 431,601 units sold. This recognition represents more than sales performance—it reflects the trust of our consumers, the strength of our science-backed innovation, and our mission to make health easier across the region.

Receiving this ASIA Records recognition in Jakarta marks another proud milestone for Wellous Indonesia and reinforces our commitment to advancing functional health food in Southeast Asia.

We look forward to continuing to break barriers, set new standards, and inspire more people to embrace beauty and health from within.”

About Wellous Indonesia

Wellous Indonesia is a health and wellness company guided by a simple philosophy: while much of the industry focuses on making supplements better, Wellous focuses on making health easier.

Believing that good health belongs to everyone, the company develops functional health products designed to translate scientific innovation into practical and accessible solutions for everyday life. Through brands including DVN, Wellous continues to serve consumers across the region with products centred on convenience, innovation, and wellness.

For more information, visit:
https://www.wellous.id/